Worcester Business Journal

4 Worcester Business Journal | June 25, 2018 | wbjournal.com of the Massachusetts Biotech Initia- tives incubator, said the city is quickly becoming a biotech destination. WuXi Biologics had been eyeing Worcester for more than a year, O'Sullivan said. "Landing them was a major mark not just for Worcester but establishing the biomanufacturing park as a leader in the industry," he said. "WuXi coming was not by mistake, but it was because we've worked hard on this." C E N T R A L M AS S I N B R I E F WuXi Biologics to build $60M Worcester facility BY ZACHARY COMEAU Worcester Business Journal Staff Writer V E R BAT I M Remembering Bourdain "We are deeply saddened by the news of Anthony Bourdain passing. We are honored to have been able to work with such a talented human in so many aspects. Rest in peace Anthony." Mike Ciprari, owner of SJC Drums, on the passing of Anthony Bourdain, who visited the Southbridge drum manufacturer last year Hard cider plans "The Brew Barn and our plans for hard cider will continue to bring new energy to our area of North Central Massachusetts." Rich Walton, owner of Moon Hill Brewing Co. in Gardner, on his plans to partner with Red Apple Farm in Phillipston for a summer brew yard and hard cider Fake test results "The state expects certified operators like the defendant to truthfully report that their waste- water discharge is safe. Falsifying wastewater samples and test results puts the health of our residents and our water quality at risk." Massachusetts Attorney General Maura Healey, on a three-year probation sentence for the owner of a Fitchburg wastewater treatment company SRA Inc. for falsifying wastewater test results A Chinese biotech company will build a $60-million facility at the Worcester Biomanufacturing Park, becoming the first tenant at the site of the former Worcester State Hospital, which the Worcester Business Development Corp. is attempting to turn into a major biotechnology hub. WuXi Biologics announced the new facility on June 10, which brings ap- proximately 150 new jobs. e facility is the firm's 11th drug manufacturing plant and first in the U.S.. e plant, dubbed the "Facility of the Future," will be built using the compa- ny's single-use bioreactors and will be designed to run continuous biopro- cessing – technology to be used in America for the first time, WuXi said. e company is poised to receive up to $21 million in public money for the project, including grants, tax credits, rent abatements, exemptions and loans from city and state sources, including Massachusetts Life Sciences Center and MassDevelopment. LakePharma, a California biologics company with a presence in Worcester, was once thought to be the anchor tenant in the Biomanufacturing Park but instead purchased a 69,000-square- foot Hopkinton facility last December. A biopharmaceutical leader e WuXi announcement comes on the heels of the 2018 BIO International Convention, a global conference of biotech and pharma leaders, which was held in Boston in June. WuXi brings a global biomanufactur- ing expertise to help enhance the state's biopharma companies develop therapies W more efficiently, said Travis McCready, president and CEO of MLSC. e company, which toured Worces- ter before committing to the site, looks to move quickly to join the state's growing biopharmaceutical industry. e site is expected to play a key role in the company's global network, Chairman Ge Li said. "Metropolitan Boston is acknowl- edged as a leader in the biopharma- ceutical industry," Li said. "e new site plays a key role in WuXi Biologics' global bio-manufacturing network to ensure that biologics are manufactured at the highest quality." Many of the company's partners are located within two hours of the new site, according to CEO Chris Chen. "We are all very excited to initiate our first U.S. site to enable local com- panies and expedite biologics develop- ment," Chen said. Kevin O'Sullivan, president and CEO PHOTO/GRANT WELKER WBDC has filed an application to tear down the Bryan Building in the Worcester Biomanufacturing Park to make way for WuXi Biologics.

• Cover